r.aldana_pharmd
TL4 Pharmacist · Valencia, ES
Hospital pharmacist, sterile compounding background. I answer reconstitution and stability questions and I am fussy about beyond-use dating because it is the part people most often get wrong.
Joined 10 May 2024 · last posted 17h · groups: pharmacists, wiki-editors, trust-level-4
191 posts, newest first. Showing up to 150.
-
What a regulator's shortage notice actually authorises Replied, post #13 · Sourcing › Regulatory · 27 Jul 2026 · 5 likes Everything in post #9 holds. The case it does not cover is the one I have. Nothing in this subcategory is legal advice, and the members who work in regulated…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #112 · Start Here › Welcome · 27 Jul 2026 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Why the Start Here categories exist, and what they are not for Replied, post #42 · Start Here › Welcome · 26 Jul 2026 · 5 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Which categories are strict and which are relaxed, honestly Replied, post #51 · Start Here › Welcome · 26 Jul 2026 · 0 likes Agreed on all of that, and I have nothing to add to it.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #31 · Clinical › Prescriber conversations · 22 Jul 2026 · 33 likes Take the actual numbers and the actual dates. A printed table beats a description and takes the first five minutes out of the appointment.
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #24 · Sourcing › Logistics · 21 Jul 2026 · 26 likes Delivery to an address where somebody is present is worth more for cold-chain material than any packing decision available to the supplier. I would put the burden of…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #49 · Clinical › Prescriber conversations · 18 Jul 2026 · 0 likes Where I part company with post #47, and it is a narrow parting. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
-
Asking a follow-up: new topic or new reply? Replied, post #59 · Start Here › How to Ask · 18 Jul 2026 · 30 likes If you are new and reading this thread for the answer to asking a follow-up: the answer is conditional, the conditions are in the third reply, and the rest of the…
-
What is genuinely unknown about long-term amylin agonism Replied, post #50 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2026 · 24 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #135 · Start Here › How to Ask · 16 Jul 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Submitting a sample: the process end to end Replied, post #86 · Sourcing › Independent verification · 16 Jul 2026 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. I have no interest in any supplier named above.
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #35 · Clinical › Comorbidities · 11 Jul 2026 · 27 likes Post #33 describes the usual case. This is about the unusual one. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral…
-
Follow-up: Signs of dehydration worth acting on Replied, post #19 · Safety › Adverse events · 9 Jul 2026 · 6 likes On Signs of dehydration worth acting: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #47 · Compounds › Retatrutide · 8 Jul 2026 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #47 · Analytics › Home & field testing · 8 Jul 2026 · 4 likes Where I part company with post #45, and it is a narrow parting. I think the home kit substitute question is answerable and has not been answered, which is a more…
-
A pooled estimate that changed when one trial was added Replied, post #19 · Evidence › Meta-analyses · 6 Jul 2026 · 27 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #15 · Sourcing › Logistics · 4 Jul 2026 · 0 likes Notice of a delay before the quoted window elapses is a materially different service experience from notice afterwards, and it is worth recording which happened.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #102 · Practice › Reconstitution · 28 Jun 2026 · 13 likes Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
-
The most useful thing you learned here that was not the answer you came for Replied, post #54 · Lounge › Off topic · 28 Jun 2026 · 0 likes Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does.
-
Submitting a sample: the process end to end Replied, post #42 · Sourcing › Independent verification · 27 Jun 2026 · 30 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #68 · Analytics › Home & field testing · 25 Jun 2026 · 8 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively.
-
Programming during a large energy deficit Replied, post #22 · Nutrition & Training › Resistance training · 22 Jun 2026 · 14 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Programming during a large energy deficit Replied, post #17 · Nutrition & Training › Resistance training · 14 Jun 2026 · 0 likes Deload weeks matter more during a deficit than at maintenance because recovery is the limiting factor.
-
Racemisation and why it is invisible to a mass measurement Replied, post #102 · Analytics › Impurities & related substances · 14 Jun 2026 · 0 likes This follows post #101 rather than contradicting it. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #21 · Start Here › Welcome · 14 Jun 2026 · 30 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #49 · Analytics › Home & field testing · 14 Jun 2026 · 11 likes I read post #45 twice before replying, because I had assumed the opposite. Precision of home tests: most consumer-accessible devices are not precise to the level people…
-
Coming back to: Storing in the door of the fridge is worse than you think Replied, post #4 · Practice › Storage & stability · 8 Jun 2026 · 14 likes What is reasonably well supported: refrigeration slows degradation, repeated warming and cooling is worse than either state alone, light exposure is worth avoiding, and…
-
Submitting a sample: the process end to end Replied, post #7 · Sourcing › Independent verification · 8 Jun 2026 · 2 likes Submitting a sample: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #108 · Sourcing › Red flags · 7 Jun 2026 · 0 likes On post #106 — agreed on the reasoning, with one qualification. A request rather than an answer: could whoever has the primary source for certificate whose chromatogram…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #17 · Evidence › Journal club · 5 Jun 2026 · 14 likes Reading this SURMOUNT-OSA thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #5 · Access › Insurance & coverage · 3 Jun 2026 · 16 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept. Caveat: everything above assumes the paperwork is what it says…
-
Prescription requirements and telehealth models — a second dataset Replied, post #51 · Sourcing › Regulatory · 3 Jun 2026 · 2 likes Two sentences on Prescription requirements and telehealth models and then I will stop, because the rest is speculation and the thread is better without mine. What is…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #64 · Practice › Storage & stability · 2 Jun 2026 · 12 likes Confirming post #61 from a second method, which matters more than confirming it from a second person. The strongest argument against my own position on Mean kinetic…
-
Programming during a large energy deficit Replied, post #6 · Nutrition & Training › Resistance training · 28 May 2026 · 0 likes Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting continuous progress during weight loss is unrealistic.
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #17 · Start Here › How to Ask · 25 May 2026 · 27 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Electrolyte supplements: which ones do anything Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 23 May 2026 · 2 likes This follows post #11 rather than contradicting it. The strongest argument against my own position on electrolyte supplements, stated as well as I can state it, since…
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #12 · Sourcing › Red flags · 21 May 2026 · 15 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. Patterns would be much easier to settle if anyone reported the…
-
Run-in periods and the population they select Replied, post #120 · Evidence › Trials · 19 May 2026 · 2 likes I would put moderate confidence on the mainstream reading of run-in periods and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #71 · Sourcing › Logistics · 16 May 2026 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
CJC-1295 with and without DAC: what the modification does Replied, post #58 · Compounds › Secretagogues & GH axis · 15 May 2026 · 11 likes Something worth flagging about CJC-1295: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #18 · Analytics › Home & field testing · 9 May 2026 · 0 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #2 · Sourcing › Vendor reports · 4 May 2026 · 14 likes Date the submission as well as the result. Turnaround is part of what people want to know and it disappears if only one date is recorded.
-
The "under review" status pill and when a moderator applies it Replied, post #106 · Evidence › Preprints · 1 May 2026 · 0 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #21 · Wellbeing › Sleep · 25 Apr 2026 · 16 likes Consumer sleep trackers measure movement and heart rate and infer stages. The inference is imprecise and the trend is more usable than the nightly numbers. The…
-
The "under review" status pill and when a moderator applies it Replied, post #86 · Evidence › Preprints · 21 Apr 2026 · 0 likes I had written a reply contradicting post #83 and deleted it. Here is what survived. Author track record is a weak signal and it is a signal. A group that has published…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #49 · Practice › Storage & stability · 20 Apr 2026 · 0 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
The best-written scientific paper you have read Replied, post #9 · Lounge › Off topic · 18 Apr 2026 · 17 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Research-use-only status: what it means legally and practically Replied, post #29 · Compounds › Other compounds · 18 Apr 2026 · 8 likes Agreed on research-use-only status, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
-
List price versus negotiated price versus what you pay Replied, post #59 · Access › Pricing · 13 Apr 2026 · 0 likes Post #55 describes the usual case. This is about the unusual one. A cheaper option that arrives slowly has a cost in the form of running out, and people rarely price…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #18 · Compounds › Repair & healing peptides · 9 Apr 2026 · 9 likes This follows post #17 rather than contradicting it. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group.…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #10 · Analytics › HPLC & UHPLC · 8 Apr 2026 · 31 likes Post #7 answers the question as asked. The question underneath it is different. Retention time is only comparable within a laboratory on a given method. Quoting a…
-
Coming back to: When a red flag was a misunderstanding, and the retraction Replied, post #2 · Sourcing › Red flags · 4 Apr 2026 · 0 likes Taking the opening post at face value and following it one step further. Inability to trace lots: if you ask "where was this synthesised, by whom, under what…
-
Forced degradation studies: designing one that is informative Replied, post #29 · Analytics › Method validation · 1 Apr 2026 · 0 likes Taking post #26 at face value and following it one step further. Reading back through the forced degradation studies threads from last year, the same three questions…
-
When your prescriber and the evidence disagree Replied, post #8 · Clinical › Prescriber conversations · 30 Mar 2026 · 8 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. That is where I would start, not where I would stop.
-
Moderation log format change Replied, post #39 · Meta › Announcements · 26 Mar 2026 · 0 likes Everything in post #35 holds. The case it does not cover is the one I have. A note on how moderation log format change gets discussed rather than on moderation log…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #61 · Practice › Interactions · 24 Mar 2026 · 1 like Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.
-
Choosing which test to pay for, given a fixed budget Replied, post #34 · Sourcing › Independent verification · 21 Mar 2026 · 0 likes Picking up post #33: that is the part I would want checked first. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
-
Managing an unplanned gap in supply Replied, post #67 · Access › Shortages · 20 Mar 2026 · 30 likes Post #63 and I disagree about the size of the effect, not about the direction. Two sentences on managing an unplanned gap and then I will stop, because the rest is…
-
The headache that turns out to be dehydration — the long version Replied, post #8 · Nutrition & Training › Hydration & electrolytes · 10 Mar 2026 · 21 likes The most useful posts here describe what was measured, what was changed, and what happened, in that order. Happy to be corrected if someone holds better data than mine.
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #9 · Data & Tools › Datasets · 7 Mar 2026 · 17 likes Marking my uncertainty on Whether an aggregate explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
The lowest dose that does anything: is that a real question? Replied, post #79 · Practice › Dosing & titration · 6 Mar 2026 · 11 likes Post #78 and I disagree about the size of the effect, not about the direction. The starting dose in most of these programmes is a tolerance step and produces little…
-
Contributing data without breaching anyone's privacy Replied, post #50 · Data & Tools › Datasets · 5 Mar 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #34 · Outcomes › Body composition · 28 Feb 2026 · 24 likes DXA on the same machine with the same technician has a least significant change for lean mass of roughly a kilogram, sometimes more. Below that, two scans are the same…
-
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #13 · Evidence › Journal club · 27 Feb 2026 · 3 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. The reason PIONEER 6 keeps being re-asked is that the answer is conditional and…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #17 · Analytics › Impurities & related substances · 22 Feb 2026 · 2 likes Post #14 put the caveat in the right place and I want to underline it. Truncation products: fragments from incomplete synthesis or from degradation. They elute quite…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #26 · Access › International · 14 Feb 2026 · 1 like Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction report different experiences honestly. The…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #38 · Analytics › Mass spectrometry · 13 Feb 2026 · 29 likes Source for the mass error in ppm figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #37 · Data & Tools › Calculators · 2 Feb 2026 · 7 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places. I…
-
Preprint servers and what screening they do Replied, post #37 · Evidence › Preprints · 28 Jan 2026 · 3 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #40 · Practice › Interactions · 27 Jan 2026 · 15 likes I came in to disagree and I am leaving without a disagreement.
-
The headache that turns out to be dehydration Replied, post #156 · Nutrition & Training › Hydration & electrolytes · 26 Jan 2026 · 26 likes Adding the measurement that post #153 says would settle it. Headache has been discussed here with more heat than it deserves, mostly because two definitions have been…
-
Temperature loggers worth the money — the long version Replied, post #120 · Devices › Cold chain · 25 Jan 2026 · 1 like Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
Reading U-100 graduations, with a conversion table Replied, post #8 · Devices › Syringes & needles · 23 Jan 2026 · 32 likes Reading U-100 graduations is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #57 · Practice › Side effects · 18 Jan 2026 · 0 likes Taking post #54 at face value and following it one step further. Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre…
-
What to include when your question involves a chromatogram Replied, post #47 · Start Here › How to Ask · 16 Jan 2026 · 10 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. A modest claim, modestly supported.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #26 · Practice › Side effects · 15 Jan 2026 · 10 likes Picking up post #25: that is the part I would want checked first. I would call the community position on muscle cramps likely rather than established, and I would be…
-
A partial dose because the pen emptied mid-injection Replied, post #118 · Practice › Administration · 11 Jan 2026 · 15 likes The single most common technique error described here is drawing to the wrong graduation because the barrel was read at an angle. Read it straight on, at eye level,…
-
How to read a forest plot, properly, from scratch Replied, post #80 · Evidence › Trials · 2 Jan 2026 · 24 likes Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #48 · Start Here › How to Ask · 2 Jan 2026 · 5 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #115 · Compounds › Oral incretins · 28 Dec 2025 · 7 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Reading SURMOUNT-1 without the press release Replied, post #116 · Compounds › Tirzepatide · 27 Dec 2025 · 1 like Answering the question post #114 raises rather than the one it answers. The honest answer on reading SURMOUNT-1 without the press is that it depends, and the useful…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #81 · Compounds › Tirzepatide · 11 Dec 2025 · 18 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Tracking a preprint to publication: a worked example Replied, post #105 · Evidence › Preprints · 10 Dec 2025 · 7 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #17 · Clinical › Bloodwork · 26 Nov 2025 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. Repeat before acting is standard practice for an isolated abnormal result on most analytes,…
-
Is "synergy" the right word for the combination data? Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 26 Nov 2025 · 0 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #19 · Practice › Reconstitution · 23 Nov 2025 · 9 likes Post #16 answers the question as asked. The question underneath it is different. Preservative effectiveness is tested against a defined microbial challenge under…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #64 · Analytics › COA interpretation · 4 Nov 2025 · 8 likes Picking up post #61: that is the part I would want checked first. The distinction between release testing and characterisation is one industrial documents make and…
-
High-resolution MS on aggregates and what it can see Replied, post #108 · Analytics › Mass spectrometry · 1 Nov 2025 · 1 like Two people in this thread mean different things by high-resolution and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
Follow-up: What a seizure notice actually says Replied, post #40 · Sourcing › Logistics · 27 Oct 2025 · 17 likes Adding a null result on seizure notice. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #96 · Practice › Storage & stability · 14 Oct 2025 · 0 likes The bit of power cut for eleven hours that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
-
Run-in periods and the population they select Replied, post #7 · Evidence › Trials · 5 Oct 2025 · 31 likes Adding a data point of agreement rather than a data point.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #27 · Data & Tools › Datasets · 30 Sep 2025 · 26 likes A dataset is only useful if the collection method is described alongside it. Numbers without a protocol are a list rather than data. Reporting the observation and…
-
"Should I double up?" — answered once, at length, calmly Replied, post #21 · Practice › Administration · 30 Sep 2025 · 4 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
-
Follow-up: Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #4 · Compounds › Retatrutide · 29 Sep 2025 · 0 likes Discontinuation for adverse effects in phase 2 was not negligible at the higher doses. That figure belongs next to the efficacy figure whenever the efficacy figure is…
-
Thyroid function tests during substantial weight change Replied, post #76 · Clinical › Bloodwork · 27 Sep 2025 · 10 likes The number people quote for thyroid function tests during substantial is a central estimate presented without its interval, and the interval is wide enough that the…
-
What pooling buys you and what it destroys Replied, post #30 · Evidence › Meta-analyses · 27 Sep 2025 · 6 likes Narrowing post #27, because the general version has more than one answer. Double extraction with disagreement resolution is standard and is worth checking for, because…
-
Revisiting: Sample size in a voluntary survey: the selection problem Started this topic · Data & Tools › Datasets · 8 Sep 2025 · 5 likes Revisiting: Sample size in a voluntary survey: the selection problem — setting out what I have, and where I think it stops being reliable. I have spent a fortnight…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #28 · Analytics › COA interpretation · 31 Aug 2025 · 0 likes Adding the measurement that post #25 says would settle it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
Asking about a compound your prescriber has not heard of Replied, post #141 · Clinical › Prescriber conversations · 29 Aug 2025 · 13 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
When a preprint is the best available evidence and we say so Replied, post #97 · Evidence › Preprints · 25 Aug 2025 · 3 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #94 · Evidence › Journal club · 23 Aug 2025 · 30 likes The arithmetic in post #93 is right; the assumption feeding it is the part to check. The baseline characteristics table is the single most useful page for the questions…
-
Which panel is worth repeating and which is worth ignoring Replied, post #91 · Clinical › Bloodwork · 22 Aug 2025 · 4 likes Narrowing post #88, because the general version has more than one answer. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker…
-
How to ask about something you suspect is a bad idea Replied, post #3 · Start Here › How to Ask · 18 Aug 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
What a documentation review can and cannot tell you Replied, post #65 · Sourcing › Independent verification · 8 Aug 2025 · 0 likes Adding the measurement that post #62 says would settle it. One more thing on documentation review that took me far too long to see: the two figures people quote are not…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #158 · Compounds › Tirzepatide · 7 Aug 2025 · 17 likes Picking up post #155: that is the part I would want checked first. SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed…
-
Travel coolers and how long they really hold Replied, post #41 · Devices › Cold chain · 4 Aug 2025 · 0 likes Before the thread moves on from travel coolers — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #7 · Compounds › Other compounds · 27 Jul 2025 · 33 likes Genuine question rather than a rhetorical one: has anyone here actually observed catalogue breadth, as opposed to read about it? The thread is long and I cannot tell.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #71 · Compounds › Oral incretins · 26 Jul 2025 · 5 likes Everything in post #69 holds. The case it does not cover is the one I have. Trial adherence in an oral trial with strict administration requirements is genuinely worse…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #147 · Compounds › Tirzepatide · 26 Jul 2025 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Triple agonism: additive, synergistic, or neither? Replied, post #71 · Compounds › Retatrutide · 24 Jul 2025 · 0 likes The strongest argument against my own position on triple agonism, stated as well as I can state it, since nobody else has yet.
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #15 · Start Here › Welcome · 20 Jul 2025 · 10 likes Reading counts toward trust level, so lurking is not wasted. That is unusual and it is the reason the levels here track familiarity rather than volume.
-
Persistent vomiting and the threshold for seeking help Replied, post #7 · Safety › Adverse events · 18 Jul 2025 · 11 likes Post #6 is right about the mechanism and I think understates the practical bit. Injection-site reactions that spread over a day or come with systemic symptoms are a…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #20 · Compounds › Repair & healing peptides · 18 Jul 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
A field-by-field walk through a certificate of analysis Replied, post #111 · Analytics › COA interpretation · 17 Jul 2025 · 3 likes Confirming post #109 from a second method, which matters more than confirming it from a second person. Reading old certificates: if a certificate is dated years ago,…
-
Coming back to: When "no data" is the complete and final answer Replied, post #44 · Compounds › Other compounds · 13 Jul 2025 · 8 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #74 · Evidence › Trials · 10 Jul 2025 · 20 likes Comparators chosen for regulatory reasons is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in…
-
Coming back to: Official shortage notices and what they authorise Replied, post #51 · Access › Shortages · 8 Jul 2025 · 21 likes Agreed on Official shortage notices, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
-
Request declined, with reasoning Replied, post #7 · Meta › Feature requests · 7 Jul 2025 · 9 likes Noted, and I have changed what I was going to do on the strength of it.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #36 · Clinical › Special populations · 7 Jul 2025 · 0 likes Taking post #35 at face value and following it one step further. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #11 · Pharmacology › Receptor biology · 29 Jun 2025 · 25 likes Narrowing post #8, because the general version has more than one answer. Species differences in receptor pharmacology are substantial in this family, which is one…
-
The C-cell question: rodent findings and their human context Replied, post #29 · Compounds › Semaglutide · 19 Jun 2025 · 4 likes Adding the boring version of c-cell question, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #7 · Analytics › Method validation · 12 Jun 2025 · 14 likes Building on post #6 rather than restating it. Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow —…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #46 · Clinical › Comorbidities · 5 Jun 2025 · 22 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #10 · Nutrition & Training › Protein & intake · 3 Jun 2025 · 30 likes Adding the measurement that post #9 says would settle it. Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows…
-
[2026 update] Splitting an overlong document into two Replied, post #7 · Documentation › Wiki requests · 31 May 2025 · 10 likes Everything in post #3 holds. The case it does not cover is the one I have. What I can speak to on Splitting an overlong document is narrow, so I will keep it narrow…
-
Pre-registering a personal experiment, seriously Replied, post #29 · Research Methods › N-of-1 designs · 28 May 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Coverage for the indication versus for the drug Replied, post #75 · Access › Insurance & coverage · 21 May 2025 · 23 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #82 · Data & Tools › Calculators · 21 May 2025 · 0 likes Nothing a calculator produces is medical advice, and a correct calculation on inappropriate inputs is still an inappropriate answer.
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #28 · Practice › Dosing & titration · 19 May 2025 · 5 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #106 · Access › Pricing · 19 May 2025 · 14 likes A cheaper option that arrives slowly has a cost in the form of running out, and people rarely price that.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #67 · Data & Tools › Calculators · 14 May 2025 · 12 likes If someone has run Validating a calculator against hand properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #105 · Practice › Reconstitution · 13 May 2025 · 30 likes Since 5 mg vial keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #3 · Sourcing › Regulatory · 10 May 2025 · 1 like Small methodological point on compound being unapproved: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #64 · Practice › Reconstitution · 6 May 2025 · 8 likes The thing about 5 mg vial that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Metformin co-administration and additive GI effects Replied, post #24 · Practice › Interactions · 30 Apr 2025 · 24 likes Thank you for the correction. I would rather find out here than later.
-
A report I filed that turned out to be wrong, and the correction Replied, post #31 · Sourcing › Vendor reports · 28 Apr 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #74 · Access › Pricing · 22 Apr 2025 · 0 likes Post #70 put the caveat in the right place and I want to underline it. The cost of an independent submission is worth stating in these threads, because it is the main…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #32 · Evidence › Journal club · 18 Apr 2025 · 11 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. The literature is thinner on this than the…
-
Which panel is worth repeating and which is worth ignoring Replied, post #3 · Clinical › Bloodwork · 12 Apr 2025 · 3 likes Panel is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Triple agonism: additive, synergistic, or neither? Replied, post #35 · Compounds › Retatrutide · 11 Apr 2025 · 1 like Appreciated. The plain phrasing does more work here than a longer post would.
-
Carryover and the ghost peak from last week's standard Replied, post #55 · Analytics › HPLC & UHPLC · 8 Apr 2025 · 3 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
What a simple presence test is genuinely useful for — does this still hold? Replied, post #3 · marked as the solution · Analytics › Home & field testing · 7 Apr 2025 · 9 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 3 Apr 2025 · 1 like Answering the question post #24 raises rather than the one it answers. Adding the boring version of cagrisema phase 2 paper, because the interesting version keeps…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #10 · Devices › Pens & autoinjectors · 1 Apr 2025 · 2 likes Picking up post #7: that is the part I would want checked first. Needle changes between doses are specified for a reason and the reasons are dose accuracy and sterility…
-
Deamidation and the close-eluting pair it produces Replied, post #16 · Analytics › Impurities & related substances · 28 Mar 2025 · 0 likes Two people in this thread mean different things by deamidation and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
Residual solvents and scavengers: what is looked for Replied, post #7 · Analytics › Impurities & related substances · 27 Mar 2025 · 14 likes This follows post #6 rather than contradicting it. Comparing impurity profiles across suppliers is much more informative than comparing purity figures, and almost…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #125 · Compounds › Other compounds · 25 Mar 2025 · 0 likes This follows post #123 rather than contradicting it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in…
-
Adjudicated events and why the definition matters — the long version Replied, post #49 · Evidence › Trials · 15 Mar 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Maintainer handover: how it works Replied, post #11 · Meta › Wiki maintenance · 13 Mar 2025 · 25 likes On post #8 — agreed on the reasoning, with one qualification. Practical experience of maintainer handover, offered as one case with the conditions stated, not as a…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #64 · Sourcing › Red flags · 12 Mar 2025 · 31 likes Answering the question post #60 raises rather than the one it answers. Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these…